Dual-head gamma camera 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in oncological patients: effects of non-uniform attenuation correction on lesion detection
M. Zimny et al., Dual-head gamma camera 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography in oncological patients: effects of non-uniform attenuation correction on lesion detection, EUR J NUCL, 26(8), 1999, pp. 818-823
Citations number
25
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
The purpose of this study was to evaluate a dual head coincidence gamma cam
era (DH-PET) equipped with single-photon transmission for 2-[fluorine-18]-f
luoro-2-deoxy-D-glucose (FDG) imaging in oncological patients. Forty-five p
atients with known or suspected malignancies, scheduled for a positron emis
sion tomography (PET) scan, were first studied with a dedicated ring PET an
d subsequently with DH-PET. All patients underwent measured attenuation cor
rection using germanium-68 rod sources for ring PET and caesium-137 sources
for DH-PET. Ring PET emission scan was started 64+/-17 min after intraveno
us administration of 235+/-42 MBq FDG, DH-PET emission followed 160+/-32 mi
n after i.v. FDG. Attenuation-corrected and non-attenuation-corrected image
s were reconstructed for ring PET and DH-PET. The image sets were evaluated
independently by three observers blinded to clinical data and to results o
f conventional imaging. Attenuation-corrected ring PET as the standard of r
eference depicted 118 lesions, non-attenuation-corrected ring PET 113 (96%)
lesions, and attenuation-corrected DH-PET and non-attenuation-corrected DH
-PET, 101 (86%) and 84 (71%) lesions, respectively (P<0.05). The lesion det
ection rate of attenuation-corrected and non-attenuation-corrected DH-PET w
as almost similar for lesions >20 mm, whereas attenuation correction increa
sed the detection rate from 60% to 80% for lesions less than or equal to 20
mm (P<0.01). A patient-based analysis revealed concordant results relative
to attenuation-corrected ring PET for non-attenuation-corrected ring PET,
attenuation-corrected DH-PET and non-attenuation-corrected DH-PET in 42 (93
%), 36 (80%) and 31 (69%) patients, respectively. Differences might have in
fluenced patient management in two (4%), six (13%) and ten (22%) patients,
respectively. In conclusion, measured attenuation correction markedly impro
ves the lesion detection capability of DH-PET. With measured attenuation co
rrection the diagnostic performance of DH-PET is closer to that of dedicate
d ring PET.